Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00264134
Recruitment Status : Terminated
First Posted : December 12, 2005
Last Update Posted : January 20, 2010
Information provided by:
Kentuckiana Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : October 2005